BTLA-BINDING (CD272) ANTIBODIES FOR MODULATING IMMUNE RESPONSE AND

The present invention provides novel anti-BTLA antibodies, pharmaceutical compositions comprising such antibodies, and therapeutic methods of using such antibodies and pharmaceutical compositions in the treatment of diseases, such as cancer or autoimmune diseases. 本发明提供了新型的抗BTLA抗体，包含这种抗体的药物组合物，以及使用这...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Hauptverfasser:	LIPPINCOTT, JOHN, ANDREW, ZABEL BENJAMIN A, ZHENG YING, RAO MAHESH VITHALRAO, TAN, MICHAEL, MEININGER, DAVID, P
Format:	Patent
Sprache:	chi ; eng
Schlagworte:	CHEMISTRY HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE METALLURGY ORGANIC CHEMISTRY PEPTIDES PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online-Zugang:	Volltext bestellen
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	The present invention provides novel anti-BTLA antibodies, pharmaceutical compositions comprising such antibodies, and therapeutic methods of using such antibodies and pharmaceutical compositions in the treatment of diseases, such as cancer or autoimmune diseases. 本发明提供了新型的抗BTLA抗体，包含这种抗体的药物组合物，以及使用这种抗体和药物组合物治疗疾病(例如癌症或自身免疫性疾病)的治疗方法。